To be noticed, Enrofloxacin seemed to downregulate bacterial clearance of BMDM and their expression of RUBCN (Figure 3C–E), which further demonstrated the superior protection against post‐stroke pneumonia of BM‐MSC compared with antibiotics. The gene discussed is RUBCN; the disease is Stroke.